The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2017T Cell-mediated Autoimmune Responses in Parkinson's Disease
Study Rationale
The protein alpha-synuclein, which is misprocessed in nearly every case of Parkinson's disease (PD), forms the Lewy bodies seen in PD patient brain. In our recent MJFF-funded study, our... -
Research Grant, 2017Using Immune Cells to Treat Parkinson's Disease
Study Rationale:
While significant strides have been made toward therapies that can prevent, slow or stop Parkinson's disease (PD) progression, no currently approved Parkinson's treatment can do this... -
Access to Data and Biospecimens, 2017An 8-protein panel for diagnosis of Parkinson’s Disease: Sample request for replication in PDBP and PPMI
Study Rationale:
We have previously found a panel of 8 proteins that can be measured in the blood that together distinguish people who have Parkinson’s Disease vs. people who do not. We are trying to...
-
Research Grant, 2017Blood Proteins for the Treatment of Parkinson’s Disease
Study Rationale & Design:
Components of blood have been found to improve health and enhance multiple biological functions in pre-clinical studies of age-related decline. Blood plasma has been... -
Research Grant, 2017Using Deep Brain Stimulation to Understand and Treat Dystonia Associated with Parkinson’s Disease
Study Rationale:
Dystonia and Parkinson's disease (PD) are closely related movement disorders. Dystonia is characterized by painful, prolonged muscle contractions that cause involuntary, repetitive... -
LRRK2 Biology Consortium, 2017Investigating the Role of LRRK2 in Immunity and Susceptibility to Infection
Study Rationale:
One of the most common inherited causes of Parkinson's disease (PD) is defect in the LRRK2 protein caused by changes, or mutations, of the LRRK2 gene. Our previous studies have shown...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.